Cargando…
Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug
AIMS: The COVID-19 disease caused by the SARS-CoV-2 has become a pandemic and there are no effective treatments that reduce the contagion. It is urgent to propose new treatment options, which are more effective in the interaction between viruses and cells. In this study was to develop a search for n...
Autores principales: | Benítez-Cardoza, Claudia Guadalupe, Vique-Sánchez, José Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294299/ https://www.ncbi.nlm.nih.gov/pubmed/32553928 http://dx.doi.org/10.1016/j.lfs.2020.117970 |
Ejemplares similares
-
Identifying compounds that prevent the binding of the SARS-CoV-2 S-protein to ACE2
por: Benítez-Cardoza, Claudia Guadalupe, et al.
Publicado: (2021) -
Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
por: Liu, Xiaofeng, et al.
Publicado: (2023) -
Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
por: Brown, Emily E. F., et al.
Publicado: (2021) -
Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
por: Lan, Jun, et al.
Publicado: (2022) -
Advanced Analysis of Biosensor Data for SARS-CoV-2
RBD and ACE2 Interactions
por: Forssén, Patrik, et al.
Publicado: (2020)